Reproductive health drugs
Executive Summary
FDA's Advisory Committee for Reproductive Health Drugs will discuss the draft guidances "Evaluation of Human Pregnancy Outcome Data" and "Establishing Pregnancy Registries Data" on Oct. 18 beginning at 9 a.m. at the Holiday Inn in Gaithersburg, Md